H.R. 1189 · 119th Congress · Health
National Plan for Epilepsy Act
- IntroducedFeb 11, 2025 Done
- CommitteeReferred to Energy and Commerce Current stage
- House floorNot yet Not reached yet
- Senate floorNot yet Not reached yet
- Chambers agreeNot yet Not reached yet
- PresidentNot yet Not reached yet
What it does
This bill requires the Department of Health and Human Services (HHS) to establish a national plan, form an advisory council, and take other actions to address epilepsy. The requirements sunset on December 31, 2035.
Specifically, the bill requires HHS to carry out a National Plan for Epilepsy to prevent, diagnose, treat, and cure epilepsy. In carrying out the plan, HHS must implement activities such as coordinating research and services across all federal agencies and soliciting public comments.
Also, HHS must establish an Advisory Council on Epilepsy Research, Care, and Services. The advisory council must report to HHS and Congress every two years with an evaluation of federally funded efforts.
Additionally, HHS must annually report to Congress with recommended actions based on its assessments of the nation’s progress on epilepsy.
Congressional Research Service · summary of “Introduced in House” version · Feb 11, 2025
Who lobbies on it
4 organizations, more than 90% of House bills · 9 filings, incl. 2 naming only S. 494 · Q1 2025–Q3 2026These 4 organizations’ PACs gave $281K to 66 of the 103 members sponsoring or cosponsoring H.R. 1189 in the 2025–26 election cycle.
One square per quarter since introduction, oldest left. Filled = named H.R. 1189 or S. 494 that quarter.
-
Lundbeck Llc
5 of 7 quarters
“…H.R. 1189 & S. 494, National Plan for Epilepsy Act Issues pertaining to prior authorization - HR 9396, Prior Authorization Accountability Act Issues pertaining to transparency - HR 9393, Lower Costs, More Transparency Act Issues pertaining to Pediatric Priority Review Voucher program at the FDA - H.R.10359, Priority…”
$440K lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both
-
Everytown for Gun Safety Action Fund
2 of 7 quarters
“H.R. 715 / S. 494 - Bipartisan Background Checks Act H.R. 8600 / S. 3369 - GOSAFE Act H.R. 38 / S. 214 - Concealed Carry Reciprocity Act H.R. 2403 / S. 1116 - Enhanced Background Checks Act H.R. 1478 / S. 4706 - Federal Firearm Licensee Act H.R. 2390 / S. 1026 - Gun Violence Prevention Research Act H.R. 768 / S. 247…”
$2.0M lobbying spend in 2026 to date, all issuesQ1 2026 filing · names S. 494 only
-
American Medical Association
1 of 7 quarters
“H.R.1189 - National Plan for Epilepsy Act H.R.2767 - BRAIN Act, all provisions S.1330 - BRAIN Act, all provisions S.494 - National Plan for Epilepsy Act Comment Letter: [OMB-2026-0034] Regulation for Federal Financial Assistance Matters related to National Institutes of Health (NIH) funding and research Matters…”
$17.6M lobbying spend in 2026 to date, all issuesQ3 2026 filing · names both
1 more organization, every filingPROUpgrade
Organizations that named H.R. 1189 or its companion S. 494 in a quarterly lobbying report. Covers organizations with a PAC on file; reports from organizations without one aren’t loaded yet. Spend is the organization’s total across all issues: reports don’t split spending by bill. Reports naming only S. 494 are included and tagged. “Gave to” means the organization’s PAC gave to the member’s campaign in the 2025–26 cycle, net of refunds; it doesn’t mean the money was about this bill. Members sponsoring the companion, S. 494, are counted on that bill’s page, not here. Organizations may lobby for, against, or to change a bill; filings don’t say which. Source: Senate lobbying disclosures (LD-2) from lda.gov; PAC gifts from FEC filings; quotes are word for word from the “specific lobbying issues” field; where a filing lists many bills, the quote starts where it names this one.
Actions
2 actions · newest first- Feb 11, 2025Referred to the House Committee on Energy and Commerce.
- Feb 11, 2025Introduced in House
What members said about it
-
Rep. Jim Costa Introduces National Plan for Epilepsy
Representatives Jim Costa (CA-21) and Greg Murphy (NC-03), Co-Chairs of the Congressional Epilepsy Caucus, introduced H.R.1189, the National Plan for Epilepsy Act, bipartisan legislation that would establish a national plan to coordinate…
“As someone who has seen firsthand how epilepsy impacts families in the San Joaquin Valley, I know we must do more to support those living with this condition.”